Cassandra Wilkinson on Muck Rack

Cassandra Wilkinson

Gotham
As seen in: PLOS, PLOS ONE, The Mandarin
Co-owner @Lazy_Thinking records |
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Cassandra

Contact Cassandra, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Exogenous ketone therapy does not protect brain tissue after moderate-sized intracerebral hemorrhage despite signs of early neurological benefit

|
By Noam H. Sander, Shubham Soni, Cassandra Wilkinson, Elmira Khiabani
| PLOS ONE
Loading metrics Open Access Peer-reviewed Research Article Citation: Sander NH, Soni S, Wilkinson CM, Khiabani E, Dyck JRB, Colbourne F (2024) Exogenous ketone therapy does not protect brain tissue after moderate-sized intracerebral hemorrhage despite signs of early neurological benefit. PLoS ONE 19(12): e0311778.
Open in Who Shared Issue with article?

A systematic review and meta-analysis on the efficacy of glibenclamide in animal models of intracerebral hemorrhage

|
By Cassandra Wilkinson, Lane Liddle, Frederick Colbourne
| PLOS ONE
Loading metrics Open Access Peer-reviewed Research Article Citation: Kung TFC, Wilkinson CM, Liddle LJ, Colbourne F (2023) A systematic review and meta-analysis on the efficacy of glibenclamide in animal models of intracerebral hemorrhage. PLoS ONE 18(9): e0292033. https://doi.org/10.1371/journal.pone.0292033 Editor: Anna-Leena Sirén, Universitatsklinikum Wurzburg, GERMANY Received: June 9, 2023; Accepted: September 11, 2023; Published: September 27, 2023 Copyright: © 2023 Kung et al.
Open in Who Shared Issue with article?

Colchicine pre-treatment and post-treatment does not worsen bleeding or functional outcome after collagenase-induced intracerebral hemorrhage

|
By Cassandra Wilkinson, Aristeidis H. Katsanos, Frederick Colbourne, Noam H. Sander
| PLOS
Loading metrics Open Access Peer-reviewed Research Article Abstract Patients with intracerebral hemorrhage (ICH) are at increased risk for major ischemic cardiovascular and cerebrovascular events. However, the use of preventative antithrombotic therapy can increase the risk of ICH recurrence and worsen ICH-related outcomes. Colchicine, an anti-inflammatory agent, has the potential to mitigate inflammation-related atherothrombosis and reduce the risk of ischemic vascular events.
Open in Who Shared Issue with article?
See all 6 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified